Thomas Ashworth CTC Symposium

Thursday 7th August 2014 Hilton Hotel, Sydney

The Inaugural Thomas Ashworth Symposium will bring together medical researchers and clinicians to advance the science and clinical utility of circulating tumour cell (CTC) and circulating tumour nucleic acid (ctNA) research.

This one day symposium (9am - 5pm) is a unique opportunity to foster growth of the Australian CTC research community. The symposium pays tribute to the Australian physician Thomas Ashworth who first oberved circulating tumor cells in 1869.


The Thomas Ashworth CTC Symposium will be open to researchers and clinicians who have an interest in the identification, isolation and characterisation of CTCs and ctNA.


The meeting will explore the latest developments in CTC enumeration, ctNA and molecular characterisation including techniques for cellular, molecular and immunological analyses, next generation sequencing and culture of CTCs. Specific focus will be on the clinical utility of CTCs and ctNA, including the prospects and current limitations how these biomarkers can aid the rational decision making in cancer therapy.


  • Prof Klaus Pantel (Director, Department of Tumor Biology, University of Hamburg,
         University Medical Center Hamburg-Eppendorf, Germany)
  • A/Prof Catherine Alix-Panabières (University Medical Center of Montpellier; France)
  • Dr Sarah-Jane Dawson (Peter MacCallum Cancer Centre, Melbourne)


Click here for more information

Click here for the Program


Kevin Spring, Organising Chair, Thomas Ashworth CTC Symposium
Associate Professor of Medical Oncology, Ingham Institute | University of Western Sydney
P: (02) 8738 9032 | E: